Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Transgene et NEC Bio signent un accord de licence pour préparer les prochaines étapes de développement de TG4050 dans les cancers de la tête et du cou
-
Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
-
REDWOOD CITY, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...
-
Spektion launches runtime exposure management to show security teams which CVEs and non-CVE risks are exploitable, cutting vulnerability noise dramatically
-
Led by Shelly Sun Berkowitz, Next Phase Capital invests $6M in Clementine’s Ice Cream to launch a national franchise strategy.
-
REDWOOD CITY, Calif., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel...
-
BALTIMORE, Feb. 24, 2026 (GLOBE NEWSWIRE) -- The Urology Care Foundation, the world’s leading nonprofit urological health foundation and the official foundation of the American Urological...
-
(Note: All dollar amounts in this news release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from unaudited consolidated financial statements prepared...
-
SAN DIEGO , Feb. 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of current, long-term shareholders of Jasper Therapeutics, Inc. (NASDAQ: JSPR), KBR,...
-
ALL Accor unveils the 8 trends set to redefine experiential travel in 2026